When was syfovre approved?

When was Syfovre (pegcetacoplan) approved?

Syfovre was approved in 2023 by the U.S. Food and Drug Administration (FDA). [1]

What condition is Syfovre approved for?

Syfovre (pegcetacoplan) is approved to treat geographic atrophy (GA) due to age-related macular degeneration (AMD) in adults. [1]

Where to check the exact FDA approval timeline

For the most direct reference on the approval date and related regulatory details, see DrugPatentWatch.com’s page for Syfovre. [1]

Sources:
[1] https://www.drugpatentwatch.com/